From professional translators, enterprises, web pages and freely available translation repositories.
vaccineffekt
vaccine efficacy
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
vaccineffekt (95 % ci)
vaccine efficacy (95% ci)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
vaccineffekt (%) mot allvarlig rotavirusgastroenterit 95 % ci
vaccine efficacy (%) against severe rotavirus gastro-enteritis (95% ci)
Last Update: 2017-04-26
Usage Frequency: 2
Quality:
förebyggande vaccineffekt efter två doser mot sjukhusvårdskrävande rvge
effectiveness after 2 doses in preventing rvge leading to hospitalisation
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
tabell 3: vaccineffekt mot aom(1) i compas
table 3: vaccine efficacy against aom(1) in compas
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
vaccineffekt mot mild till måttlig symptomatisk covid 19 bekräftad av nukleinsyraförstärkningstest
vaccine efficacy against mild to moderate symptomatic covid 19 confirmed by nucleic acid amplification test
Last Update: 2021-10-23
Usage Frequency: 1
Quality:
Reference:
data på vaccineffekt hos barn >36 månaders ålder tyder på ett avtagande skydd.
vaccine efficacy results in children > 36 months of age suggest a waning of protection.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Reference:
Warning: Contains invisible HTML formatting
tabell 5: vaccineffekt mot höggradiga cervikala lesioner oavsett hpv dna-typ i lesionen
table 5: vaccine efficacy against high-grade cervical lesions irrespective of the hpv dna type in the lesion
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Reference:
tabell 4: vaccineffekt mot virologiska endpoint orsakade av hpv 16/18 (tvc)
table 4: vaccine efficacy against virological endpoints associated with hpv-16/18 (tvc)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Reference:
en statistiskt signifikant vaccineffekt påvisades dessutom mot cin 2+ orsakad av hpv 16 och hpv 18 var för sig.
in addition, statistically significant vaccine efficacy against cin2+ associated with hpv-16 and hpv-18 individually was demonstrated.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Reference:
tabell 3: vaccineffekt mot höggradiga cervikala lesioner orsakade av hpv 16/18 (tvc)
table 3: vaccine efficacy against high grade cervical lesions associated with hpv-16/18 (tvc)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Reference:
vaccineffekt mot höggradiga cervikala lesioner orsakade av hpv 16/18 som observerats i tvc vid studiens slut visas i tabell 3.
vaccine efficacy against high grade cervical lesions associated with hpv-16/18 observed in tvc at end of study is presented in table 3.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Reference:
ytterligare en analys utfördes för att avgöra vaccineffekt mot lesioner som sannolikt är orsaksmässigt förknippade med hpv 16 och/ eller hpv 18.
an additional analysis was conducted to determine vaccine efficacy against lesions likely to be causally associated with hpv-16 and/ or hpv-18.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
Reference:
tabell 1: vaccineffekt mot höggradiga cervikala lesioner orsakade av hpv 16/18 (atp-kohort)
table 1: vaccine efficacy against high grade cervical lesions associated with hpv-16/18 (atp cohort)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Reference:
22 emellertid statistisk signifikans avseende 12 månaders persisterande infektion för hpv 18 med en vaccineffekt på 89, 9% (97, 9% ci:
22 tvc-1 analysis except that it excluded women with abnormal cytology at study entry, the 12 month persistent infection endpoint for hpv-18 reached statistical significance with vaccine efficacy of 89.9% (97.9% ci:
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
Reference:
under första levnadsåret, rapporterade signifkant färre försökspersoner i rotarix-gruppen allvarlig rotavirus gastroenterit orsakad av cirkulerande vildtyp rv jämfört med placebogruppen, från 2 veckor efter dos 2 upp till ett års ålder (0,0 % mot 0,3 % ) med en vaccineffekt på 100 % (95 % ci: 72,2 %; 100).
during the first year, significantly fewer subjects in the rotarix group reported severe rotavirus gastro- enteritis caused by the circulating wild-type rv compared to the placebo group from 2 weeks after dose 2 up to one year of age (0.0% versus 0.3%), with a vaccine efficacy of 100% (95% ci: 72.2; 100).
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
Reference: